Doximity – Analysts’ Recommendations and Stock Price Forecast (2024)
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst’s rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock’s consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat’s consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat’s consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Consensus Rating
Hold
Based on 15 Analyst Ratings
Consensus Price Target
| High Forecast | $33.00 |
|---|---|
| Average Forecast | $28.73 |
| Low Forecast | $23.00 |
| Type | Current Forecast 6/9/23 to 6/8/24 |
1 Month Ago 5/10/23 to 5/9/24 |
3 Months Ago 3/11/23 to 3/10/24 |
1 Year Ago 6/9/22 to 6/9/23 |
|---|---|---|---|---|
| Consensus Rating |
Hold |
Hold |
Hold |
Hold |
| Strong Buy |
0 Strong Buy rating(s) |
0 Strong Buy rating(s) |
0 Strong Buy rating(s) |
0 Strong Buy rating(s) |
| Buy |
3 Buy rating(s) |
2 Buy rating(s) |
2 Buy rating(s) |
3 Buy rating(s) |
| Hold |
11 Hold rating(s) |
11 Hold rating(s) |
9 Hold rating(s) |
4 Hold rating(s) |
| Sell |
1 Sell rating(s) |
1 Sell rating(s) |
1 Sell rating(s) |
3 Sell rating(s) |
| Consensus Price Target | $28.73 | $28.82 | $28.30 | $36.30 |
| Forecasted Upside | -2.59% Downside | 7.92% Upside | 6.03% Upside | 0.86% Upside |
Get Doximity Upgrade and Downgrade Alerts
Sign-up to receive the latest news and ratings for DOCS and its competitors with MarketBeat’s FREE daily newsletter.
DOCS Analyst Recommendations By Month
The chart below shows how a company’s ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
DOCS Price Targets by Month
The chart below shows how a company’s share price and consensus price target have changed over time. The dark blue line represents the company’s actual price. The lighter blue line represents the stock’s consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table
Doximity Stock vs. The Competition
| Type | Doximity | Medical Companies | S&P 500 |
|---|---|---|---|
| Consensus Rating Score |
2.13 |
2.69 |
2.50 |
| Consensus Rating | Hold | Moderate Buy | Hold |
| Predicted Upside | -2.59% Downside | 864.54% Upside | 11.01% Upside |
| News Sentiment Rating | Neutral News |
Positive News |
Positive News |
Recent Analyst Forecasts and Stock Ratings
Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:23 AM ET.
DOCS Frequently Asked Questions
-
What is Doximity’s stock forecast and purchase recommendation?
-
According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Doximity is $28.73, with a high forecast of $33.00 and a low forecast of $23.00. The consensus rating for Doximity stock is Hold based on the current 1 sell rating, 11 hold ratings and 3 buy ratings for DOCS. Learn more on DOCS’s analyst rating history.
-
Do Wall Street analysts like Doximity more than its competitors?
-
Analysts like Doximity less than other “medical” companies. The consensus rating for Doximity is Hold while the average consensus rating for “medical” companies is Moderate Buy. Learn more on how DOCS compares to other companies.
-
Is Doximity being upgraded by Wall Street analysts?
-
Over the previous 90 days, Doximity’s stock had 1 upgrade by analysts.
-
Does Doximity’s stock price have much upside?
-
According to analysts, Doximity’s stock has a predicted upside of 8.57% based on their 12-month stock forecasts.
-
What analysts cover Doximity?
